Commercial products (herbal supplements) containing the kava plant (Piper methysticum), known to have the anxiolytic activity are the suspicion of a potential liver toxicity. We have investigated the effects of administration of commercial kava products on gene expression of hepatic CYP1A isoforms in rats.